RSS Feed
August 4th, 2021 
Awake Goy 
“As the inventor of the messenger RNA (mRNA) vaccine platform, Dr. Robert Malone is one of the most qualified individuals to opine on the benefits and potential risks of this technology.”
Story at-a-glance
- Safety data analysis and reporting in clinical trials of the COVID jabs appear to have been manipulated in at least some cases. One method for manipulating randomized clinical trial safety data is to only analyze the “per protocol” treatment group (those who completed all doses and were fully compliant with the study design) as opposed to “intent to treat” which would include all patients that have signed informed consent
- For example, if a participant only accepted one dose and trial protocol called for two, under a “per protocol” analysis, adverse events they experienced would be dismissed and not included in the safety analysis. This is a classic way to manipulate safety data in clinical research, and it’s usually forbidden
- Since the COVID shots only have emergency use authorization, they are experimental products and, as such, they are not authorized for marketing
- Bioethics are written into federal law. As an experimental trial participant, you have the right to receive full disclosure of any adverse event risks. Full disclosure of risks is not being done, and in fact is being suppressed
- Adverse event risks must also be communicated in a way that you can comprehend what the risks are, and the acceptance of an experimental product must be fully voluntary and uncoerced. Enticement is strictly forbidden
READ MORE
Related posts:
Biden: Trump Has 'Put a Lot of Pressure' on Scientists at CDC and FDA, I'd Trust Fauci on Vaccine
Interview 1756 - James Corbett on The Darkened Hour
Australian Court Blocks Covid Vaccine Challenge
France Considers Mandating Covid Boosters For Vaccine Passport
The Vaccine Industry’s Biggest Threat? The Science of Wild Oregano Oil & The Diseases It Can Kil...
Trump Urges Americans to Get Covid-19 Vaccine: ‘I Would Recommend It’
Posted in 
Tags: 
